Adage Capital Partners Gp, L.L.C. Evolus, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Evolus, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 486,400 shares of EOLS stock, worth $5.84 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
486,400Holding current value
$5.84 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
178Shares Held
50.4MCall Options Held
42.2KPut Options Held
2.5K-
Perceptive Advisors LLC New York, NY5.15MShares$61.8 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$60 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$48.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$38.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$37.6 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $674M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...